Activity and safety of lenalidomide and dexamethasone in patients with multiple myeloma requiring dialysis: a Spanish multicenter retrospective study

被引：28
|
作者：
de la Rubia, Javier [1 ,2 ]
Roig, Monica [1 ]
Ibanez, Angela [3 ]
Garcia, Inmaculada [5 ]
Vera, Jose A. [4 ]
Aguilar, Carlos [6 ]
del Campo, Raquel [7 ]
Gonzalez, Nicolas [8 ]
Martinez, Rafael [9 ]
Palomera, Luis [10 ]
Picon, Isabel [11 ]
Rodriguez, Juan N. [12 ]
Sanz, Miguel A. [1 ]
机构：
[1] Hosp La Fe, E-46009 Valencia, Spain
[2] Univ Catolica San Vicente Martir, Valencia, Spain
[3] Gen Hosp, Albacete, Spain
[4] Hosp Virgen Macarena, Seville, Spain
[5] Gen Hosp, Castellon de La Plana, Spain
[6] Hosp Santa Barbara, Soria, Spain
[7] Hosp Son Llatzer, Palma de Mallorca, Spain
[8] Hosp Gen Obispo Polanco, Teruel, Spain
[9] Hosp Clin San Carlos, Madrid, Spain
[10] Hosp Lozano Blesa, Zaragoza, Spain
[11] Inst Valenciano Oncol, Valencia, Spain
[12] Hosp Juan Ramon Jimenez, Huelva, Spain
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2010年 / 85卷 / 04期
关键词：
RENAL-FAILURE; PLUS DEXAMETHASONE; THALIDOMIDE; COMBINATION; THERAPY;
D O I：
10.1111/j.1600-0609.2010.01500.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：363 / 365
页数：3
相关论文
共 50 条
  • [41] Access and safety of dexamethasone in multiple myeloma patients
    Slimano, Florian
    Tournamille, Jean-Francois
    Bardin, Christophe
    Madelaine, Isabelle
    Hulin, Cyrille
    Moreau, Philippe
    Rioufol, Catherine
    BULLETIN DU CANCER, 2023, 110 (06) : 731 - 733
  • [42] Carfilzomib, Lenalidomide, and Dexamethasone vs Lenalidomide and Dexamethasone in Patients (Pts) with Relapsed Multiple Myeloma: Interim Results from ASPIRE, a Randomized, Open-Label, Multicenter Phase 3 Study
    Stewart, A. Keith
    Rajkumar, S. Vincent
    Dimopoulos, Meletios A.
    Masszi, Tamas
    Spicka, Ivan
    Oriol, Albert
    Hajek, Roman
    Rosinol, Laura
    Siegel, David S.
    Mihaylov, Georgi G.
    Goranova-Marinova, Veselina
    Rajnics, Peter
    Suvorov, Aleksandr
    Niesvizky, Ruben
    Jakubowiak, Andrzej
    San Miguel, Jesus F.
    Ludwig, Heinz
    Zojwalla, Naseem
    Tonda, Margaret E.
    Xing, Biao
    Moreau, Philippe
    Palumbo, Antonio
    BLOOD, 2014, 124 (21)
  • [43] Survival of Patients with Multiple Myeloma That Is Refractory to Both Bortezomib and Lenalidomide: A Retrospective Study
    Miyazaki, Kanji
    Suzuki, Kenshi
    BLOOD, 2018, 132
  • [44] Interim results from ASPIRE, a randomized, open-label, multicenter phase 3 study evaluating carfilzomib, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone in patients with relapsed multiple myeloma
    Stewart, A. K.
    Rajkumar, S. V.
    Dimopoulos, M. A.
    Mihaylov, G. G.
    Goranova-Marinova, V.
    Rajnics, P.
    Suvorov, A.
    Jakubowiak, A. J.
    San-Miguel, J. F.
    Zojwalla, N.
    Moreau, P.
    Palumbo, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 : 20 - 20
  • [45] Post-authorization safety of lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma in Turkey
    Tuglular, Ayse Tulin Firatli
    Pehlivan, Mustafa
    Sonmez, Mehmet
    Hacioglu, Sibel Kabukcu
    Saydam, Guray
    Ayyildiz, Orhan
    Kaynar, Leylagul
    Demirkan, Fatih
    Beksac, Meral
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S190 - S191
  • [46] Efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma
    M A Dimopoulos
    A S Swern
    J S Li
    M Hussein
    L Weiss
    Y Nagarwala
    R Baz
    Blood Cancer Journal, 2014, 4 : e257 - e257
  • [47] Efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma
    Dimopoulos, M. A.
    Swern, A. S.
    Li, J. S.
    Hussein, M.
    Weiss, L.
    Nagarwala, Y.
    Baz, R.
    BLOOD CANCER JOURNAL, 2014, 4 : e257 - e257
  • [48] The efficacy and safety of lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma patients with impaired renal function
    Weber, D. M.
    Spencer, A.
    Wang, M.
    Chen, C.
    Attal, M.
    Niesvizky, R.
    Prince, M.
    Yu, Z.
    Knight, R.
    Dimopoulos, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [49] Efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma: a real-life experience
    Soyer, Nur
    Patir, Pusem
    Uysal, Ayse
    Duran, Mustafa
    Unal, Hatice Demet
    Durusoy, Raika
    Tombuloglu, Murat
    Sahin, Fahri
    Tobu, Mahmut
    Vural, Filiz
    Saydam, Guray
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (04) : 777 - 785
  • [50] The Efficacy and Safety of Lenalidomide Plus Dexamethasone in Relapsed and/or Refractory Multiple Myeloma Patients With Impaired Renal Function
    Dimopoulos, Meletios
    Alegre, Adrian
    Stadtmauer, Edward A.
    Goldschmidt, Hartmut
    Zonder, Jeffrey A.
    de Castro, Carlos M.
    Masliak, Zvenyslava
    Reece, Donna
    Olesnyckyj, Marta
    Yu, Zhinuan
    Weber, Donna M.
    CANCER, 2010, 116 (16) : 3807 - 3814
12345